NCT05142462

Brief Summary

EUROSCUP Fixe is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP Fixe performances and safety

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
75mo left

Started Oct 2021

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress42%
Oct 2021Jul 2032

Study Start

First participant enrolled

October 27, 2021

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

November 24, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 2, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2022

Completed
9.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2032

Expected
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

9 months

First QC Date

November 24, 2021

Last Update Submit

February 16, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Safety of EUROSCUP Fixe

    Collect the safety of the device trought complications occurence rate

    1 year

Secondary Outcomes (3)

  • Clinical performances of EUROSCUP Fixe

    1 year

  • Radiological performances of EUROSCUP Fixe

    1 year

  • Survival of EUROSCUP Fixe

    10 years

Study Arms (1)

EUROSCUP Fixe

120 patients who received EUROSCUP Fixe

Device: Hip arthroplasty

Interventions

Hip prosthesis surgical implantation

EUROSCUP Fixe

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient who fulfill the criteria of eligilibilty according to the instructions for use of EUROSCUP Fixe

You may qualify if:

  • Patient who received EUROSCUP Fixe.
  • Patient informed of its participation to the study
  • Patient aged between 18 and 80 years old (\<80).

You may not qualify if:

  • Patient presenting a contraindication to EUROSCUP Fixe implantation.
  • Patient who refused to participate to the study
  • Vulnerable subjects

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Clinique Esquirol Saint Hilaire

Agen, 47000, France

Location

Clinique de L'Atlantique

Puilboreau, 17138, France

Location

Centre Hospitalier SECLIN

Seclin, 59113, France

Location

Clinique St Roch

Toulon, 83000, France

Location

MeSH Terms

Conditions

Osteoarthritis, HipHip FracturesHip Dislocation

Interventions

Arthroplasty, Replacement, Hip

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesFemoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg InjuriesJoint Dislocations

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2021

First Posted

December 2, 2021

Study Start

October 27, 2021

Primary Completion

July 29, 2022

Study Completion (Estimated)

July 1, 2032

Last Updated

February 20, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations